Iberdomide plus low-dose cyclophosphamide and dexamethasone in patients with relapsed and refractory multiple myeloma (the ICON study): a multicentre, single-arm, phase 2 trial in Interne Geneeskunde
Physical activity patterns after diagnosis and survival of prognostic colorectal cancer subgroups in Chirurgie